ESTRO ACROP and SIOPE recommendations for myeloablative Total Body Irradiation in children

dc.contributor
Institut Català de la Salut
dc.contributor
[Hoeben BAW] Dept. of Radiation Oncology, University Medical Center Utrecht, The Netherlands. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. [Pazos M, Losert C] Dept. of Radiation Oncology, University Hospital, LMU Munich, Germany. [Seravalli E, Bosman ME] Dept. of Radiation Oncology, University Medical Center Utrecht, The Netherlands. [Albert MH] Dept. of Pediatrics, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, Germany. [Mico Milla S] Servei d’Oncologia Radioteràpica, Vall d'Hebron Hospital Universitari, Barcelona, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Hoeben, Bianca
dc.contributor.author
Pazos, Montserrat
dc.contributor.author
Seravalli, Enrica
dc.contributor.author
Bosman, Mirjam
dc.contributor.author
Losert, Christoph
dc.contributor.author
Albert, Michael
dc.contributor.author
Mico Milla, Soraya
dc.date.accessioned
2025-10-24T10:29:29Z
dc.date.available
2025-10-24T10:29:29Z
dc.date.issued
2022-09-12T08:33:02Z
dc.date.issued
2022-09-12T08:33:02Z
dc.date.issued
2022-08
dc.identifier
Hoeben BAW, Pazos M, Seravalli E, Bosman ME, Losert C, Albert MH, et al. ESTRO ACROP and SIOPE recommendations for myeloablative total body irradiation in children. Radiother Oncol. 2022 Aug;173:119–33.
dc.identifier
0167-8140
dc.identifier
https://hdl.handle.net/11351/8141
dc.identifier
10.1016/j.radonc.2022.05.027
dc.identifier
35661674
dc.identifier
000806106000001
dc.identifier.uri
https://hdl.handle.net/11351/8141
dc.description.abstract
Consensus recommendations; Pediatric; Total Body Irradiation
dc.description.abstract
Recomanacions de consens; Pediatria; Irradiació corporal total
dc.description.abstract
Recomendaciones de consenso; Pediatría; Irradiación corporal total
dc.description.abstract
Background and purpose Myeloablative Total Body Irradiation (TBI) is an important modality in conditioning for allogeneic hematopoietic stem cell transplantation (HSCT), especially in children with high-risk acute lymphoblastic leukemia (ALL). TBI practices are heterogeneous and institution-specific. Since TBI is associated with multiple late adverse effects, recommendations may help to standardize practices and improve the outcome versus toxicity ratio for children. Material and methods The European Society for Paediatric Oncology (SIOPE) Radiotherapy TBI Working Group together with ESTRO experts conducted a literature search and evaluation regarding myeloablative TBI techniques and toxicities in children. Findings were discussed in bimonthly virtual meetings and consensus recommendations were established. Results Myeloablative TBI in HSCT conditioning is mostly performed for high-risk ALL patients or patients with recurring hematologic malignancies. TBI is discouraged in children <3–4 years old because of increased toxicity risk. Publications regarding TBI are mostly retrospective studies with level III–IV evidence. Preferential TBI dose in children is 12–14.4 Gy in 1.6–2 Gy fractions b.i.d. Dose reduction should be considered for the lungs to <8 Gy, for the kidneys to ≤10 Gy, and for the lenses to <12 Gy, for dose rates ≥6 cGy/min. Highly conformal techniques i.e. TomoTherapy and VMAT TBI or Total Marrow (and/or Lymphoid) Irradiation as implemented in several centers, improve dose homogeneity and organ sparing, and should be evaluated in studies. Conclusions These ESTRO ACROP SIOPE recommendations provide expert consensus for conventional and highly conformal myeloablative TBI in children, as well as a supporting literature overview of TBI techniques and toxicities.
dc.format
application/pdf
dc.language
eng
dc.publisher
Elsevier
dc.relation
Radiotherapy and Oncology;173
dc.relation
https://doi.org/10.1016/j.radonc.2022.05.027
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Scientia
dc.subject
Infants
dc.subject
Cèl·lules mare hematopoètiques - Trasplantació - Complicacions
dc.subject
Radioteràpia
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Cell- and Tissue-Based Therapy::Cell Transplantation::Stem Cell Transplantation::Hematopoietic Stem Cell Transplantation
dc.subject
Other subheadings::Other subheadings::Other subheadings::/adverse effects
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Radiotherapy::Whole-Body Irradiation
dc.subject
NAMED GROUPS::Persons::Age Groups::Child::Child, Preschool
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::tratamientos basados en células y tejidos::trasplante de células::trasplante de células madre::trasplante de células madre hematopoyéticas
dc.subject
Otros calificadores::Otros calificadores::Otros calificadores::/efectos adversos
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::radioterapia::irradiación corporal total
dc.subject
DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño::niño preescolar
dc.title
ESTRO ACROP and SIOPE recommendations for myeloablative Total Body Irradiation in children
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)